This inventor holds 1 USPTO granted patent and 7 published patent applications. Top assignee: Gilead Sciences, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Joshua D. Farr: Innovator in PRMT5 Inhibitors
Introduction
Joshua D. Farr is a notable inventor based in Mountain View, CA (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that inhibit PRMT5. His work is crucial for advancing treatments for various diseases and conditions.
Latest Patents
Joshua D. Farr holds a patent for "PRMT5 inhibitors and uses thereof." This patent relates to compounds that inhibit PRMT5 and outlines their use in preparing medicaments for treating diseases associated with chromosome 9p21 deletion, MTAP null, or any other MTAP deficiency. Additionally, the patent discusses the application of these compounds in cancer treatment.
Career Highlights
Farr is currently employed at Gilead Sciences, Inc., where he continues to innovate in the field of pharmaceuticals. His work focuses on developing effective treatments that target specific genetic and molecular pathways.
Collaborations
Joshua has collaborated with notable colleagues, including Megan K. Armstrong and Elbert Chin, to further enhance the research and development of PRMT5 inhibitors.
Conclusion
Joshua D. Farr's contributions to the field of medicinal chemistry, particularly through his patent on PRMT5 inhibitors, highlight his role as an innovator in developing targeted therapies for serious health conditions. His work at Gilead Sciences, Inc. continues to pave the way for advancements in cancer treatment and other related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile